Results of Meeting
Released
Released
Announcement PDF
ASX ANNOUCEMENT
2024 Annual General Meeting – Results of
Meeting
30 May 2024
Elixinol Wellness Ltd (ASX:EXL) (“EXL”, “Elixinol”, “Company” or “Group”), wishes to
announce the results of the Company’s Annual General Meeting held at 11:00am
today.
In accordance with ASX Listing Rule 3.13.2, the Company confirms that all
resolutions in the Company’s 2024 Notice of Annual General Meeting were
passed. Each resolution was determined by a poll at the meeting.
Further, in accordance with ASX Listing Rule 3.13.2 and section 251AA(2) of the
Corporations Act 2001 (Cth), the Company provides the results of the Annual
General Meeting voting in the attachment to this announcement.
This document was authorised for release by the Board of the Company.
For further information, please contact:
David Fenlon, Non-executive Chair
david.fenlon@elixinolwellness.com
Pauline Gately, Non-executive Director
Pauline.Gately@elixinolwellness.com
PO Box 20547, World Square, NSW, 2002 Australia
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
About Elixinol Wellness
Elixinol Wellness Limited (ASX: EXL) is a leader in the global hemp industry,
innovating, marketing, and selling hemp and other plant-derived food, skincare,
and nutraceutical products:
In Australia, Elixinol Wellness operates a vertically integrated business which
produces, manufactures, and distributes a range of highly complementary
products delivered across four verticals – human nutrition, human wellness, pet
wellness and superfood ingredients. These products are sold under brands
including Hemp Foods Australia, Mt Elephant, Ananda Food, Soul Foods and Field
Day and are sold through grocery, wholesale, and e-commerce channels. The
Australian Superfood Co also supplies Australian natives and superfood
ingredients to white label customers as well as food, beverage, and beauty
manufacturers.
In the Americas, Elixinol Wellness sells high quality Elixinol branded hemp and
other plant-derived nutraceutical and skincare products.
In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp
and other plant-derived products are available to consumers via exclusive
distribution and/or trademark and know-how licensing agreements.
See more at www.elixinolwellness.com
PO Box 20547, World Square, NSW, 2002 Australia
info@elixinolwellness.com | www.elixinolwellness.com | @EXLWellness
Disclosure of Proxy Votes
Automic
GPO Box 5193, Sydney, NSW 2001
P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world)
F +61 (0)2 8583 3040 E hello@automic.com.au
ABN 27 152 260 814
Elixinol Wellness Limited
Annual General Meeting
Thursday, 30 May 2024
In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting.
Poll Results (if
applicable)
Proxy Votes
Resolution
Decided by
Show of
Hands (S) or
Poll (P)
Total Number of
Proxy Votes
exercisable by
proxies validly
appointed
1 Election of Director – Ms Natalie Butler
P
105,354,107
2 Election of Director – Ms Pauline Gately
P
87,460,726
3 Remuneration Report
P
75,805,267
4 Approval of Issue of Shares to Mr Ronald Dufficy
P
105,304,328
5 Approval of Issue of Director Fee Rights to Mr David
Fenlon
P
105,313,087
6 Approval of Issue of Director Fee Rights to Ms
Pauline Gately
P
87,420,706
7 Approval of Additional Share Issue Capacity under
ASX Listing Rule 7.1A
P
105,353,835
FOR
AGAINST
101,793,456
477,651
96.62%
0.45%
83,900,075
477,651
95.93%
0.55%
70,058,187
2,767,919
92.42%
3.65%
101,130,476
1,284,916
96.04%
1.22%
101,137,002
1,287,149
96.03%
1.22%
83,266,769
1,265,001
95.25%
1.45%
101,287,212
1,177,687
96.14%
1.12%
ABSTAIN
29,258
17,922,639
728
79,037
70,278
17,962,659
29,530
PROXY'S
DISCRETION
FOR
AGAINST
3,083,000
115,970,750
477,651
2.93%
99.59%
0.41%
3,083,000
98,077,369
477,651
3.53%
99.52%
0.48%
2,979,161
73,046,434
2,767,919
3.93%
96.35%
3.65%
2,888,936
115,113,706
1,284,916
2.74%
98.90%
1.10%
2,888,936
115,120,232
1,287,149
2.74%
98.89%
1.11%
2,888,936
87,319,416
1,265,001
3.30%
98.57%
1.43%
2,888,936
115,270,442
1,177,687
2.74%
98.99%
1.01%
Results
ABSTAIN
OUTCOME
29,258
Passed
17,922,639
Passed
728
-
79,037
Passed
70,278
Passed
17,962,659
Passed
29,530
Passed
Share your feedback
Discover